Latest teriflunomide Stories
Once-daily oral medication to be reimbursed for first-line use MISSISSAUGA, ON, May 25, 2015 /CNW/ - Genzyme, a Sanofi company, announced today that PEI Pharmacare has included
MISSISSAUGA, ON, Feb.
PARIS, October 26, 2010 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the initiation of a multinational Phase III study evaluating the efficacy and safety of two doses of once daily teriflunomide (7mg or 14mg) versus placebo in patients with relapsing multiple sclerosis (RMS) treated with interferon beta (IFN beta). Teriflunomide is a novel oral disease modifier developed by sanofi-aventis which is being investigated in a large Phase III clinical...
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.